|
COMMD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77515999999489E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.640800E-04 |
| Normal-vs-Stage2 |
2.036100E-04 |
| Normal-vs-Stage3 |
1.60125999999483E-05 |
| Normal-vs-Stage4 |
1.89929999949712E-07 |
| Stage1-vs-Stage2 |
2.171200E-01 |
| Stage1-vs-Stage3 |
6.850300E-02 |
| Stage1-vs-Stage4 |
8.581300E-03 |
| Stage2-vs-Stage3 |
9.164600E-01 |
| Stage2-vs-Stage4 |
2.710800E-01 |
| Stage3-vs-Stage4 |
2.559200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7791999999961E-06 |
| Normal-vs-AfricanAmerican |
9.034100E-02 |
| Normal-vs-Asian |
9.409700E-02 |
| Caucasian-vs-AfricanAmerican |
1.640590E-01 |
| Caucasian-vs-Asian |
2.754100E-02 |
| AfricanAmerican-vs-Asian |
8.245800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.24569999998747E-06 |
| Normal-vs-Female |
6.41329999999662E-05 |
| Male-vs-Female |
2.973400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.917900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.2053999999837E-06 |
| Normal-vs-Age(61-80Yrs) |
2.64400000005161E-06 |
| Normal-vs-Age(81-100Yrs) |
3.762400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.114100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.265900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.178200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.434400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.904600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.502000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.308800E-01 |
| Classical-VS-Follicular |
3.031400E-01 |
| Classical-VS-Other |
5.493600E-01 |
| Classical-VS-Normal |
2.197500E-04 |
| Tall-VS-Follicular |
6.798800E-01 |
| Tall-VS-Other |
9.887400E-01 |
| Tall-VS-Normal |
4.556600E-04 |
| Follicular-VS-Other |
8.371600E-01 |
| Follicular-VS-Normal |
4.575300E-04 |
| Other-VS-Normal |
4.701800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.16210000000872E-05 |
| Normal-vs-N1 |
1.70628999999201E-05 |
| N0-vs-N1 |
1.401200E-01 |
|
|
